VTE in Maternal Mortality: ThrombUS+ Horizon Europe Project and Elvira Grandone
“Maternal death during pregnancy, childbirth, or the postpartum period remains a major tragedy for families and communities. Although less than 1% of global maternal deaths occur in high-income countries, it is estimated that approximately 50% of these deaths are potentially preventable.
In line with the Sustainable Development Goals (2016–2030), European countries are also called to action to eliminate avoidable maternal and neonatal deaths. A critical first step is the improvement of data monitoring and reporting, ensuring that no maternal, fetal, or neonatal death goes unnoticed.
Recent data from the Italian Obstetric Surveillance System (ItOSS) revealed significant geographic disparities in maternal mortality across Italy, with higher rates in Southern regions (10.5 per 100,000 live births) compared to the North (7.7) and Center (5.9).
Among maternal deaths occurring within 42 days postpartum, direct obstetric causes accounted for 55.1%, with obstetric hemorrhage being the leading cause (37.1%), followed by sepsis (13.9%), hypertensive disorders (13.4%), and notably, venous thromboembolism (VTE) at 11.9%.
These findings highlight the urgent need for enhanced prevention, early recognition, and management of VTE, a still under-recognized but significant contributor to maternal mortality in Italy.
Data from ItOSS – Italian Obstetric Surveillance System
Data from Elvira Grandone, Ospedale Casa Sollievo della Sofferenza”
Stay informed with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis